Clinical Trial 46474

Hurst, TX 76054


Protenium Clinical Research (Hurst, TX) is currently seeking volunteers who are at high risk of SARS-CoV-2 infection to participate in a clinical trial to evaluate an investigation drug for prevention of the SARS-CoV-2 infection.

Our team of researchers are now enrolling adults and adolescent who have not previously tested positive for SARS-CoV-2 infection and who are at high risk for COVID-19, to participate in a clinical trial consisting of up to 15 visits over a period of 14 months.

Those at high risk for SARS-CoV-2 include, but are not limited to, household contact or occupational/recreational exposure to an individual with a diagnosis of SARS-CoV-2 infection, or housing, recreational and/or social conditions that are likely to increase risk of exposure to SARS-CoV-2.

Participants will be asked to complete an e-Diary throughout the duration of the study. 

Qualified Participants May Receive:

Eligible participants will be compensated for each completed visit.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.